Revolution Medicines (RVMD) Receivables - Net (2020 - 2023)
Revolution Medicines (RVMD) posted Receivables - Net of $1.3 million for Q4 2023, up 305.83% on a QoQ basis from $309000.0 in Q3 2023, and down 73.16% year-over-year from $4.7 million in Q4 2022.
Revolution Medicines (RVMD) Receivables - Net (2020 - 2023) Analysis & Trends
Revolution Medicines has reported Receivables - Net for 4 years, with the latest figure at $1.3 million in Q4 2023.
- On a quarterly basis, Receivables - Net fell 73.16% year-over-year to $1.3 million in Q4 2023; TTM through Dec 2023 was $1.3 million, a 73.16% decrease from a year earlier, with the FY2023 full-year figure at $1.3 million, down 73.16% from the prior year.
- Receivables - Net was $1.3 million for Q4 2023 at Revolution Medicines, up from $309000.0 in the prior quarter.
- The five-year high for Receivables - Net was $7.6 million in Q1 2021, with the low at $309000.0 in Q3 2023.
- Average Receivables - Net over 4 years is $4.8 million, with a median of $5.4 million recorded in 2022.
- The sharpest annual moves came in 2021 and 2023: Receivables - Net slipped 7.26% in 2021, then tumbled 93.74% in 2023.
- Over 4 years, Receivables - Net stood at $6.4 million in 2020, then retreated by 7.26% to $5.9 million in 2021, then declined by 21.18% to $4.7 million in 2022, then sank by 73.16% to $1.3 million in 2023.
- The last three Receivables - Net figures came in at $1.3 million (Q4 2023), $309000.0 (Q3 2023), and $2.5 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 309,000.00 |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.67 Mn |
| Sep 30, 2022 | 4.94 Mn |
| Jun 30, 2022 | 5.62 Mn |
| Mar 31, 2022 | 5.38 Mn |
| Dec 31, 2021 | 5.93 Mn |
| Sep 30, 2021 | 7.41 Mn |
| Jun 30, 2021 | 6.53 Mn |
| Mar 31, 2021 | 7.56 Mn |
| Dec 31, 2020 | 6.39 Mn |
Revolution Medicines Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=RVMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();